Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.A US District Court jury in Arizona has found that certain of WL Gore & Associates' ePTFE vascular grafts and stent-grafts infringe a patent belonging to medical technology company CR Bard, and has awarded damages of $185 million.
Subscribe to our email newsletter
The jury also found that Gore willfully infringed the patent. In a second phase of the trial, the court is currently assessing Gore’s assertion that the patent is unenforceable due to inequitable conduct.
Bard expects that Gore will file post-trial motions with the court with respect to the jury’s decision. After a judgment is entered, the case may be appealed to the Court of Appeals for the Federal Circuit.